Well........things have gotten a bit quiet here. I am most disappointed because of the plausibility of the technology. No one on the planet has ever developed a true 6 log kill decontamination system. The only reason I stayed on board after 2013 was the success at Belleville. I guess we all hoped that the technology would win out in the end. The problem was that no one knew about it during the early years of development.
Recouping these assets can be done by focusing on small companies that also have game-changing technology.....but are visible, have engaged management, testing in progress, annual meetings, and have analyst following. I am keeping an eye on Aurinia AUPH...in a Phase 3 test for lupus nephritis (with another indication for macular degeneration), and CTSO Cytosorbents which already has European approval for treating a variety of bacterial related disorders like sepsis.